» Articles » PMID: 20799358

Different Disparities of Gender and Race Among the Thrombotic Thrombocytopenic Purpura and Hemolytic-uremic Syndromes

Overview
Journal Am J Hematol
Specialty Hematology
Date 2010 Aug 28
PMID 20799358
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Thrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS) represent multiple disorders with diverse etiologies. We compared the gender and race of 335 patients enrolled in the Oklahoma TTP-HUS Registry across 21 years for their first episode of TTP or HUS to appropriate control groups. The relative frequency of women and white race among patients with TTP-HUS-associated with a bloody diarrhea prodrome and the relative frequency of women with quinine-associated TTP-HUS were significantly greater than their control populations. The relative frequency of women and black race among patients with idiopathic TTP and TTP-associated with severe ADAMTS13 deficiency was significantly greater than their control populations. The relative frequency of black race among patients who had systemic lupus erythematosus (SLE) preceding TTP was significantly greater than among a population of patients with SLE, and the relative frequency of black race among patients with other autoimmune disorders preceding TTP was significantly greater than their control population. No significant gender or race disparities were present among patients with hematopoietic stem cell transplantation-associated thrombotic microangiopathy, TTP associated with pregnancy, or TTP associated with drugs other than quinine. The validity of these observations is supported by the enrollment of all consecutive patients across 21 years from a defined geographic region, without selection or referral bias. These observations of different gender and race disparities among the TTP-HUS syndromes suggest the presence of different risk factors and may serve as starting points for novel investigations of pathogenesis.

Citing Articles

Immune thrombotic thrombocytopenic purpura: pathogenesis and novel therapies: a narrative review.

Liu S, Zheng X Ann Blood. 2024; 8.

PMID: 39100389 PMC: 11296612. DOI: 10.21037/aob-22-29.


Trends and Outcomes of Hospitalizations Due to Hemolytic Uremic Syndrome: A National Perspective.

Lingas E, Mulayamkuzhiyil Saju J, Abdulqader M, Yolmo D, Shaikh M, Rupasinghe P Cureus. 2023; 14(12):e32315.

PMID: 36628001 PMC: 9825057. DOI: 10.7759/cureus.32315.


Long-term follow-up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post-HERCULES study.

Scully M, Rubia J, Pavenski K, Metjian A, Knobl P, Peyvandi F J Thromb Haemost. 2022; 20(12):2810-2822.

PMID: 36138517 PMC: 9827931. DOI: 10.1111/jth.15892.


A Rare Association of Thrombotic Thrombocytopenic Purpura with Systemic Lupus Erythematosus in a Sudanese Woman: Case Report.

Ibn Idris Rodwan A, Elmansour O, Ahmed A, Elagib E, Ahmed Eltahir N, Hassan A J Blood Med. 2021; 12:945-949.

PMID: 34785968 PMC: 8579963. DOI: 10.2147/JBM.S334689.


Major adverse cardiovascular events in survivors of immune-mediated thrombotic thrombocytopenic purpura.

Brodsky M, Sukumar S, Selvakumar S, Yanek L, Hussain S, Mazepa M Am J Hematol. 2021; 96(12):1587-1594.

PMID: 34460124 PMC: 8616844. DOI: 10.1002/ajh.26341.


References
1.
Kojouri K, Vesely S, George J . Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: frequency, clinical features, and long-term outcomes. Ann Intern Med. 2001; 135(12):1047-51. DOI: 10.7326/0003-4819-135-12-200112180-00008. View

2.
Kremer Hovinga J, Vesely S, Terrell D, Lammle B, George J . Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood. 2009; 115(8):1500-11. DOI: 10.1182/blood-2009-09-243790. View

3.
George J . Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med. 2006; 354(18):1927-35. DOI: 10.1056/NEJMcp053024. View

4.
McCarty D, Manzi S, Medsger Jr T, Ramsey-Goldman R, LaPorte R, Kwoh C . Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum. 1995; 38(9):1260-70. DOI: 10.1002/art.1780380914. View

5.
McMinn J, George J . Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy. J Clin Apher. 2002; 16(4):202-9. DOI: 10.1002/jca.10005. View